Research Center for Evidence-Based Medicine, Health Management and Safety Promotion Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Iranian EBM Centre: A Joanna Briggs Institute Affiliated Group, Tabriz, Iran.
Curr Pharm Biotechnol. 2020;21(7):555-565. doi: 10.2174/1389201021666200107113812.
Probiotics and their nutrient sources (prebiotics) have been shown to have positive effects on different organs of the host. The idea of their potential benefits on Central Nervous Systems (CNS) and the incidence of Anxiety, Schizophrenia, Alzheimer, Depression, Autism, and other mental disorders has proposed a new category of medicines called "psychobiotic" which is hoped to be of low-side effect anti-inflammatory, antidepressant, and anti-anxiety constitutes.
In the current review, we present valuable insights into the complicated interactions between the GI microbiota (especially in the colon), brain, immune and central nervous systems and provide a summary of the main findings of the effects of pro- and prebiotics on important mental disorders from the potential mechanisms of action to their application in clinical practice.
Google Scholar, Pub Med, Scopus, and Science Direct databases were searched using following key words: "probiotics", "prebiotics", "mental disorders", "psychological disorders", "depression", "anxiety", "stress", "Alzheimer" and "autism spectrum". The full text of potentially eligible studies was retrieved and assessed in detail by the reviewers. Data were extracted and then summarized from the selected papers.
The results of the provided evidence suggest that probiotic and prebiotics might improve mental function via several mechanisms. The beneficial effects of their application in Depression, Anxiety, Alzheimer and autism spectrum diseases have also been supported in clinical studies.
Pro and prebiotics can improve mental health and psychological function and can be offered as new medicines for common mental disorders, however, more clinical studies are necessary to conduct regarding the clinical significance of the effects and their bioequivalence or superiority against current treatments.
益生菌及其营养源(益生元)已被证明对宿主的不同器官具有积极影响。它们对中枢神经系统(CNS)和焦虑、精神分裂症、阿尔茨海默病、抑郁症、自闭症和其他精神障碍的潜在益处的想法提出了一种新的药物类别,称为“心理益生菌”,有望成为低副作用的抗炎、抗抑郁和抗焦虑药物。
在本次综述中,我们深入探讨了胃肠道微生物群(特别是结肠)、大脑、免疫和中枢神经系统之间的复杂相互作用,并从潜在作用机制到临床应用总结了益生菌和益生元对重要精神障碍的主要影响的主要发现。
使用以下关键词在 Google Scholar、Pub Med、Scopus 和 Science Direct 数据库中进行搜索:“益生菌”、“益生元”、“精神障碍”、“心理障碍”、“抑郁”、“焦虑”、“压力”、“阿尔茨海默病”和“自闭症谱系”。检索并详细评估潜在合格研究的全文。从选定的论文中提取和总结数据。
提供的证据结果表明,益生菌和益生元可能通过多种机制改善精神功能。它们在抑郁症、焦虑症、阿尔茨海默病和自闭症谱系障碍中的应用也得到了临床研究的支持。
益生菌和益生元可以改善心理健康和心理功能,可以作为治疗常见精神障碍的新药,但需要进行更多的临床研究来评估其疗效的临床意义及其与现有治疗方法的生物等效性或优越性。